Research and Markets: Crohn's Disease – Pipeline Review, H1 2015

DUBLIN–(BUSINESS WIRE)–Research and Markets (
has announced the addition of the “Crohn’s
Disease – Pipeline Review, H1 2015”
report to their offering.

This report provides comprehensive information on the therapeutic
development for Crohn’s Disease, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Crohn’s
Disease and special features on late-stage and discontinued projects.

the report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from the proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources, put together by the team. Drug
profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.

The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.

Companies Mentioned

Partial list of the 70+ companies mentioned in this comprehensive report:

  • 4SC
  • AB Science
  • Baliopharm
  • Calypso Biotech
  • Celgene
  • Daiichi Sankyo
  • DBV Technologies
  • Effimune
  • Eisai
  • Farmacija d.o.o. Tuzla
  • Ferring International Center
  • Galapagos
  • Genentech
  • iCo Therapeutics
  • Idera Pharmaceuticals
  • Johnson & Johnson
  • Kyorin Pharmaceutical
  • Mabion
  • Mesoblast
  • Neovacs
  • Oncobiologics
  • Oncodesign
  • Pfenex
  • Pfizer
  • Qu Biologics
  • Receptos
  • Sandoz International
  • Selexys Pharmaceuticals
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries
  • Virobay
  • Winston Pharmaceuticals

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals